get a key
steadybase-$ company STVN
account_id none on file
legal_name Stevanato Group S.p.A.
ticker STVN
cik 1849853
domain stevanatogroup.com
entry_point_account_id none on file
exchange NYSE
sector Health Care
calls 0 filings 60 executives 0 family 0
why_now
To satisfy this market need, we identified specific actions to convert an underutilized ready-to-use vial line to a ready-to-use cartridge line at our headquarters in Piombino Dese.

May 15, 2026 / receipt

callsnone on file
filings
China expansion paused.

ir_statement / Sep 16, 2026 / receipt

Next phase of RTU cartridge production: commercial production exp. to launch at the end of 2026

ir_statement / Sep 16, 2026 / receipt

Shifted geographic expansion to Latina; driven by anchor customer preference

ir_statement / Sep 16, 2026 / receipt

FX and unmitigated tariffs

ir_statement / Sep 16, 2026 / receipt

Impact of capacity expansion projects: higher depreciation and ramp-up inefficiencies

ir_statement / Sep 16, 2026 / receipt

Underperformance in Engineering Segment

ir_statement / Sep 16, 2026 / receipt

Gross profit margin increased 460 bps to 15.3%, as we start to realize some benefits from our optimization plan such as right-sizing operations and an improved labor cost structure led to better perfo

ir_statement / Sep 16, 2026 / receipt

Elongated sales cycles has led to low backlog and slow pace of new orders

ir_statement / Sep 16, 2026 / receipt

Optimizing footprint, increasing efficiencies by harmonizing our industrial processes, and streamlining activities into more defined structures, leading to an improved cost structure

ir_statement / Sep 16, 2026 / receipt

Strengthened commercial teams and increased business development to drive new order intake.

ir_statement / Sep 16, 2026 / receipt

During the three months ended March 31, 2026, and the three months ended March 31, 2025, the Group recorded €0.3 million and €1.3 million, respectively, of restructuring and related charges among cost

ir_statement / Sep 16, 2026 / receipt

During the three months ended March 31, 2026, and the three months ended March 31, 2025, the Group recorded €1.8 million and €0.8 million, respectively, of start-up costs for the new plants in Fishers

ir_statement / Sep 16, 2026 / receipt

executivesnone on file
familynone on file
upcoming
2026-11-05 earnings call scheduled ir
changesnone on file
mcp_package_hint
steadybase-$